About ACTA

Aims & Objectives

On behalf of its members, ACTA will have a role in:

 

  • promoting the advantages and benefits of investigator-initiated clinical trials and clinical quality registries;
  • raising awareness of the need for, and valuable contributions of, clinical trials networks, trial coordinating centres and clinical quality registries within the healthcare system;
  • bringing focus to common issues impacting the conduct of clinical trials and clinical quality registries;
  • facilitating collaboration among clinical trials networks, trial coordinating centres and clinical quality registries;
  • coordinating communication and consultation with clinician researchers;
  • providing expert advice on investigator-initiated clinical trials and clinical quality registries to Governments, policymakers and others;
  • developing policy recommendations for improving the quality and impact of investigator-initiated clinical trials and clinical quality registries;
  • supporting the development of new clinical trials networks and clinical quality registries that conduct, or support the conduct of investigator-initiated clinical trials;
  • encouraging capacity building for the clinical research workforce;
  • promoting education and training opportunities for clinical researchers;
  • coordinating projects, with the aim of improving all aspects of clinical trials and registries including efficiency;
  • fostering effective partnerships between clinician researchers and Governments, policy-makers, health care providers, industry and consumers;